These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17024761)

  • 1. Once-daily dosing and the treatment of HIV disease.
    Laurence J
    AIDS Read; 2006 Sep; 16(9):444-5. PubMed ID: 17024761
    [No Abstract]   [Full Text] [Related]  

  • 2. A once-daily combination tablet (Atripla) for HIV.
    Med Lett Drugs Ther; 2006 Sep; 48(1244):78-9. PubMed ID: 17001298
    [No Abstract]   [Full Text] [Related]  

  • 3. New once-daily HIV combination better tolerated.
    Expert Rev Anti Infect Ther; 2004 Dec; 2(6):826. PubMed ID: 15566325
    [No Abstract]   [Full Text] [Related]  

  • 4. Collaboration begins on combined drug.
    AIDS Patient Care STDS; 2005 Feb; 19(2):129. PubMed ID: 15747431
    [No Abstract]   [Full Text] [Related]  

  • 5. One pill, once daily: now an option for HIV patients.
    Sax PE
    AIDS Clin Care; 2006 Sep; 18(9):77. PubMed ID: 16995270
    [No Abstract]   [Full Text] [Related]  

  • 6. First of a kind in HIV treatment.
    FDA Consum; 2006; 40(6):34. PubMed ID: 17333565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efavirenz + emtricitabine + tenofovir: new combination. HIV infection: do not modify ongoing therapy just to use one less tablet. Better adherence than with separate dosing has not been demonstrated, while reduced efficacy is plausible.
    Prescrire Int; 2009 Jun; 18(101):105. PubMed ID: 19637416
    [No Abstract]   [Full Text] [Related]  

  • 8. No changes in efavirenz plasma concentrations in HIV-infected patients who switch from Stocrin to Atripla.
    Burger D; van Luin M; Bosch M; van der Ven A; Brouwer AM; Keuter M; Dofferhoff T; Koopmans PP
    J Acquir Immune Defic Syndr; 2010 Aug; 54(5):e12-3. PubMed ID: 20647821
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efavirenz in fixed combination with tenofovir and emtricitabine. Long-term effectiveness verified in new studies].
    Wepner U
    MMW Fortschr Med; 2011 May; 153(18):20-1. PubMed ID: 21604586
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug interactions. Super pills-the treatments of the future?
    TreatmentUpdate; 2006; 18(3):2-3. PubMed ID: 17209236
    [No Abstract]   [Full Text] [Related]  

  • 11. Number of daily pills, dosing schedule, self-reported adherence and health status in 2010: a large cross-sectional study of HIV-infected patients on antiretroviral therapy.
    Gianotti N; Galli L; Bocchiola B; Cahua T; Panzini P; Zandonà D; Salpietro S; Maillard M; Danise A; Pazzi A; Lazzarin A; Castagna A
    HIV Med; 2013 Mar; 14(3):153-60. PubMed ID: 22994659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent FDA approvals and changes.
    AIDS Patient Care STDS; 2010 Feb; 24(2):133-4. PubMed ID: 20156092
    [No Abstract]   [Full Text] [Related]  

  • 13. Warning on two specific 3-drug regimens: Viread + Didanosine + either Sustiva or Viramune.
    AIDS Treat News; 2004 Oct; (406):5. PubMed ID: 15614963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA notifications. Generic efavirenz/emtricitabine/fenofovir has tentative approval.
    AIDS Alert; 2009 Oct; 24(10):119-20. PubMed ID: 20034141
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and efficacy of tenofovir/emtricitabine or abacavir/lamivudine in combination with efavirenz in treatment naïve HIV patients: a 5 year retrospective observational cohort study. (the TOKEN Study).
    Pammi M; Arumainayagam J; Kumari B; Ahmed-Jushuf I; Carlin EM; Chandramani S; Riddell L; Ghanem M; Das S
    Int J Clin Pract; 2013 Sep; 67(9):922-3. PubMed ID: 23952469
    [No Abstract]   [Full Text] [Related]  

  • 16. Gilead AIDS pill effective in study with weekends off.
    AIDS Read; 2008 Dec; 18(12):593. PubMed ID: 19123271
    [No Abstract]   [Full Text] [Related]  

  • 17. Once-daily single-tablet regimens: a long and winding road to excellence in antiretroviral treatment.
    Llibre JM; Clotet B
    AIDS Rev; 2012; 14(3):168-78. PubMed ID: 22833060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of HIV-related diffuse large B-cell lymphoma in response to antiviral therapy alone.
    Amengual JE; Zhang X; Ibrahim S; Gardner LB
    Blood; 2008 Nov; 112(10):4359-60. PubMed ID: 18988884
    [No Abstract]   [Full Text] [Related]  

  • 19. Loss of control of HIV viremia associated with the fat malabsorption drug orlistat.
    Kent SJ
    AIDS Res Hum Retroviruses; 2012 Sep; 28(9):961-2. PubMed ID: 22280308
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiretroviral chemoprophylaxis: new successes and questions.
    Mayer KH
    Lancet; 2015 Jun; 385(9984):2236-7. PubMed ID: 25769358
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.